Hongming Chen
Hongming Chen is the Chief Scientific Officer at Kala Pharmaceuticals, Inc. Kala is the licensee of the MPP technology and is developing the technology for applications in various mucosal organs including the eye
False
Advertisement
The Nano State
September 8, 2014
Imagine prescribing eye drops to treat wet AMD, or delivering genes to the retina of patients with retinitis pigmentosa. Nanotechnology can do both – and it could potentially transform ophthalmology
1 min read
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False
Advertisement